Is there a role for the no observed adverse effect level in safety pharmacology?
Mow T, Andersen NK, Dragsted N, Lassen AB, Laursen M, Bass AS, Valentin JP, Markgraf C, Authier S, Baird TJ, Bhatt S, Traebert M, Leishman DJ, Jones D, Curtis MJ.
Mow T, et al. Among authors: bhatt s.
J Pharmacol Toxicol Methods. 2020 Sep;105:106917. doi: 10.1016/j.vascn.2020.106917. Epub 2020 Aug 29.
J Pharmacol Toxicol Methods. 2020.
PMID: 32866658